Prescription drug · ANDA
Mesna NDC 55150-520
Mesna 100 mg/mL · Injection, Solution · Intravenous · Eugia US LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 55150-520-01 | 55150052001 | 1 VIAL, MULTI-DOSE in 1 BOX (55150-520-01) / 10 mL in 1 VIAL, MULTI-DOSEMarketed from Jan 27, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Mesna
- Generic name (nonproprietary)
- mesna
- Active ingredients
- Mesna — 100 mg/mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Labeler
- Eugia US LLCNDC labeler code 55150
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 220518
- Marketing start
- Listing expires
- Identifiers
- Product ID 55150-520_49e9c804-9e88-4774-8faf-35bd61b3a8e9SPL ID 49e9c804-9e88-4774-8faf-35bd61b3a8e9SPL set ID 49e9c804-9e88-4774-8faf-35bd61b3a8e9RxCUI 204870UNII NR7O1405Q9UPC 0355150520015
- Pharmacologic class
- Cytoprotective Agent
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N455150052001followed by a unit qualifier and the quantityPackage 55150-0520-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
1. INDICATIONS AND USAGE Mesna injection is indicated as a prophylactic agent in reducing the incidence of ifosfamide-induced hemorrhagic cystitis. Limitation of Use: Mesna injection is not indicated to reduce the risk of hematuria due to other pathological conditions such as thrombocytopenia. Mesna injection is a cytoprotective agent indicated as a prophylactic agent in reducing the incidence of ifosfamide-induced hemorrhagic cystitis. ( 1 ) Limitation of Use: Mesna injection is not indicated to reduce the risk of hematuria due to other pathological conditions such as thrombocytopenia. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 55150-520
- What is NDC 55150-520?
- 55150-520 is the product NDC for Mesna, Mesna 100 mg/mL injection, solution, listed with the FDA by Eugia US LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Mesna.
- What is the active ingredient?
- Mesna.
- Who is the labeler?
- Eugia US LLC, NDC labeler code 55150. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Mesna?
- 7 other product NDCs are listed under this name. See all Mesna NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Mesna products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Mesna | Mesna 400 mg/1 | Tablet, Film coatedOral | Ingenus Pharmaceuticals, LLC | 50742-354 | 50742-0354-01 |
| Mesnamesna injection | Mesna 100 mg/mL | SolutionIntravenous | Gland Pharma Limited | 68083-161 | 68083-0161-0168083-0161-10 |
| Mesna | Mesna 100 mg/mL | Injection, SolutionIntravenous | Sagent Pharmaceuticals | 25021-201 | 25021-0201-1025021-0201-11 |
| mesna | Mesna 100 mg/mL | Injection, SolutionIntravenous | Hikma Pharmaceuticals USA Inc. | 0143-9260 | 00143-9260-01 |
| Mesna | Mesna 100 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 63323-733 | 63323-0733-1063323-0733-11 |
| Mesna | Mesna 100 mg/mL | Injection, SolutionIntravenous | Baxter Healthcare Company | 10019-951 | 10019-0951-05 |
| Mesna | Mesna 100 mg/mL | Injection, SolutionIntravenous | Baxter Healthcare Company | 10019-953 | 10019-0953-0110019-0953-02 |